Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients - A Pilot Study

Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients

Inclusion Criteria:

• Age 18-85
• Possible autoimmune encephalitis
• Patients who have been diagnosed and treated for encephalitis for more than 4 weeks
• Patients with epilepsy (EEG finding or clinically)

Exclusion Criteria:

• septic shock, fever >38.5 ℃, O2 saturation <90%, respiratory rate >25, HR >120
• previously, mRS=3 or mRS>3
• MMSE<20
• Patients who have terminal disease
• eye problem
• pregnancy